A Biobehavioral/Cognitive Treatment for Stress, Depression, and Anxiety in Patients With Stage IV Lung Cancer
Advanced Lung Carcinoma, Metastatic Lung Carcinoma, Stage IV Lung Cancer AJCC v8
About this trial
This is an interventional supportive care trial for Advanced Lung Carcinoma
Eligibility Criteria
Inclusion Criteria:
- Individuals diagnosed with advanced (stage IV) lung cancer with diagnosis and staging confirmed by pathology report
- Moderate to severe symptoms of depression (>= 8 on Patients Health Questionaire-9) and/or moderate to severe symptoms of anxiety (>= 10 on Generalized Anxiety Disorder-7; GAD-7)
- English-speaking
- Willingness to provide access to medical records, provide biospecimens, and responses to patient reported outcome (PRO) assessments
- Ability to understand and willingness to sign an informed consent document
Exclusion Criteria:
- Patients to be treated with definitive chemo-radiotherapy
- Presence of untreated brain metastases
- Previous lung cancer diagnosis
- Presence of disabling hearing, vision, or impairing psychiatric conditions (e.g., psychosis, bipolar disorder, substance abuse) preventing consent or completion of self-report measures in English
- Imminent risk of suicide that precludes outpatient treatment
- Currently receiving psychological treatment/counseling
Sites / Locations
- Ohio State University Comprehensive Cancer Center
Arms of the Study
Arm 1
Experimental
Supportive care (ABC session, surveys, biospecimen collection)
Phase 1 of the intervention (10 weeks) will follow the following agenda: 1) Overview and progressive muscle relaxation, 2) Seeking and asking for disease-related and treatment-related information, 3) Problem solving skills, 4) Breathing techniques and sleep hygiene, 5) Assertive communication skills, 6) Identifying social network, 7) Asking for support, 8) Further information on social support, 9) Physical activity, and 10) Review of major topics, transition. Phase 2 of the intervention (4 weeks) which will be completed only by patients who do not experience remission in depressive symptoms by the end of phase 1, will follow the following agenda: 1) Identifying negative thoughts and problematic thinking patterns, 2) Generating alternative thoughts, 3) Behavioral activation, and 4) Review and wrap-up, transition to optional maintenance. Each session in Phase 1 and Phase 2 occurs once per week, for 60 minutes each. Maintenance sessions occur monthly, 60 minutes each.